Clinical Trial Update: Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

View source ↗

Summary

This clinical trial update notes an ongoing study evaluating the pathological positivity rate in prostate cancer patients with PI-RADS 4 and a first negative bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Prostate Cancer | Status: RECRUITING